跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LpxC-1
首页
药物
LpxC-1
LpxC-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
INTERMEDIATES USEFUL FOR THE PREPARATION OF AN LPXC ANALOG, AND PROCESSES FOR THEIR PREPARATION
EP 4499610 C0
申请人: ZOETIS SERVICES LLC
优先权: 2022
CN
EP
US
WO
4 件公开
Hydroxamic acid derivative
US 9073821 B2
申请人: TAKASHIMA HAJIME
优先权: 2010
US
2 件公开
COMPOUND SERVING AS PRODRUG OF HYDROXAMIC ACID OR SALT OF SAID COMPOUND, FREEZE-DRIED MEDICINAL PREPARATION, LpxC INHIBITOR, AND ANTIBACTERIAL
CN 110248950 A
申请人: TOYAMA CHEMICAL CO LTD
优先权: 2017
CN
PYRIDINONE AND PYRIMIDINONE PHOSPHATES AND BORONATES USEFUL AS ANTIBACTERIAL AGENTS
CN 111867600 A
申请人: PFIZER
优先权: 2018
CN
NOVEL IMIDAZOLE DERIVATIVE
CN 112996505 A
申请人: TAISHO PHARMACEUTICAL CO LTD
优先权: 2018
CN
Biunit vaccine, recombinant expression vector, preparation method and application
CN 117025648 A
申请人: UNIV SHENYANG AGRICULTURAL
优先权: 2023
CN
药物
反馈